Ledger.Open graph →

SEC Form D · Amendment · filed April 20, 2017

Velicept Therapeutics, Inc

Offering

$26.3M

Sold

$18.4M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MALVERN, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James Walker · Malvern, PAExec · Director Douglas Gessl · Malvern, PAExec Scott Morenstein · New York, NYDirector David Hirsch · Greenwich, CTDirector Stephen Tullman · Malvern, PADirector James Bennethum · Gaylord, MIDirector Likai C. Lin · Boston, MADirector John Shields · Wakefield, MAExec · Director John Giordano · Wakefield, MADirector Dave Blundin · Wakefield, MADirector Sunil K. Gottipati · Princeton, NJDirector Stanley R. Westreich · Germantown, MDExec Gregory A. Ellis · New York, NYDirector I. R. Garr · Germantown, MDExec Tiffany Freitas · Wakefield, MADirector Paul Abelow · Morganville, NJDirector Dawn A. Cummings · Grand Cayman, Cayman IslandsDirector Amir Haleem · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗